Conversely, like GLP1-RAs [40], SGLT2 inhibitors activate the AMP-dependent protein kinase (AMPK) pathway, which comprises a crucial signaling mechanism regulating cellular growth, e.g., by suppressing fatty acid synthesis as well as proliferation and survival among cancer cells [52]. Here, GLP1R is linked to cancer.